Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Knapstein

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Der Urologe. Ausg. A|January 1, 1974
[Effect of estradiol, diethylstilbestrol, progesterone, and gestonorone capronate (depostat) on the 5 alpha-reductase kinetics in benign prostatic hypertrophy (BPH) (author's transl)]J E Altwein, A Rubin, K Klose, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 1, 2001
Hypoxia-stimulated expression of angiogenic growth factors in cervical cancer cells and cervical cancer-derived fibroblastsH Pilch, K Schlenger, E Steiner, et al.
Clinical Chemistry and Laboratory Medicine|March 27, 1999
Urokinase and plasminogen activator-inhibitor (PAI-1) status in primary ovarian carcinomas and ovarian metastases compared to benign ovarian tumors as a function of histopathological parametersG Hoffmann, K Pollow, W Weikel, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Der Urologe. Ausg. A|January 1, 1974
[Effect of estradiol, diethylstilbestrol, progesterone, and gestonorone capronate (depostat) on the 5 alpha-reductase kinetics in benign prostatic hypertrophy (BPH) (author's transl)]J E Altwein, A Rubin, K Klose, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 1, 2001
Hypoxia-stimulated expression of angiogenic growth factors in cervical cancer cells and cervical cancer-derived fibroblastsH Pilch, K Schlenger, E Steiner, et al.
Clinical Chemistry and Laboratory Medicine|March 27, 1999
Urokinase and plasminogen activator-inhibitor (PAI-1) status in primary ovarian carcinomas and ovarian metastases compared to benign ovarian tumors as a function of histopathological parametersG Hoffmann, K Pollow, W Weikel, et al.
Pageof 3